Cargando…

The pharmacological research of Tek-1 relevance to anti-neuroinflammation, a candidate compound based on Telmisartan

In this paper, BV-2 mouse small glial cell inflammation model induced by LPS is established. The experiment used 0.1–10 μM of telmisartan and Tek-1 to incubate with small glial cell and used telmisartan and Tek-1 to incubate with PPAR gamma special heterosexual antagonistic anti-agent GW9662. The ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianbo, Cui, Changcong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368865/
https://www.ncbi.nlm.nih.gov/pubmed/28352734
http://dx.doi.org/10.1515/med-2015-0077
Descripción
Sumario:In this paper, BV-2 mouse small glial cell inflammation model induced by LPS is established. The experiment used 0.1–10 μM of telmisartan and Tek-1 to incubate with small glial cell and used telmisartan and Tek-1 to incubate with PPAR gamma special heterosexual antagonistic anti-agent GW9662. The article used ELISA method to dectect TNF-a effect on small glial cell for telmisartan and Tek-1. The article used real-time quantitative PCR method to dectect mRNA level expression effect of CD11b, CD16 and iNOS on small glial cell for telmisartan and Tek-1 and used Western Blot method to dectect MAPKs signal pathway and NF-κb signal turned guide pathway effect on small glial cell for telmisartan and Tek-1. Results show that Tek-1 had high affinity with AT1 receptor and inhibited intracellular calcium ion activation which can be for the AT1 receptor antagonists. Meanwhile, Tek-1 can partially activate PPAR gamma compared with full agonists of rosiglitazone.